% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Fischer:137404,
author = {Fischer, Andre},
title = {{E}pigenetic memory: the {L}amarckian brain.},
journal = {The EMBO journal},
volume = {33},
number = {9},
issn = {0261-4189},
address = {Hoboken, NJ [u.a.]},
publisher = {Wiley},
reportid = {DZNE-2020-03726},
pages = {945-967},
year = {2014},
abstract = {Recent data support the view that epigenetic processes play
a role in memory consolidation and help to transmit acquired
memories even across generations in a Lamarckian manner.
Drugs that target the epigenetic machinery were found to
enhance memory function in rodents and ameliorate disease
phenotypes in models for brain diseases such as Alzheimer's
disease, Chorea Huntington, Depression or Schizophrenia. In
this review, I will give an overview on the current
knowledge of epigenetic processes in memory function and
brain disease with a focus on Morbus Alzheimer as the most
common neurodegenerative disease. I will address the
question whether an epigenetic therapy could indeed be a
suitable therapeutic avenue to treat brain diseases and
discuss the necessary steps that should help to take
neuroepigenetic research to the next level.},
subtyp = {Review Article},
keywords = {Alzheimer Disease: genetics / Alzheimer Disease:
physiopathology / Animals / Brain: physiopathology /
Epigenesis, Genetic / Gene Expression Regulation / Histones:
metabolism / Humans / Memory / RNA, Untranslated: physiology
/ Histones (NLM Chemicals) / RNA, Untranslated (NLM
Chemicals)},
cin = {AG Fischer},
ddc = {570},
cid = {I:(DE-2719)1410002},
pnm = {342 - Disease Mechanisms and Model Systems (POF3-342)},
pid = {G:(DE-HGF)POF3-342},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:24719207},
pmc = {pmc:PMC4193930},
doi = {10.1002/embj.201387637},
url = {https://pub.dzne.de/record/137404},
}